This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 02/24/2020
Location: Silver Spring, MD
Subject: FDA Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Industry, government, academia and media

Event Date: 02/26/2020
Location: Washington, DC
Subject: National Association of State Departments of Agriculture Winter Policy Conference
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Industry, government, and media

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 02/27/2020
Location: Orlando, FL
Subject: Lake Nona Impact Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other invited guests

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 02/27/2020
Location: Baltimore, MD
Subject: 2020 Center for Medicare and Medicaid Services (CMS) Quality Conference: Drug Pricing and Payment
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from Centers for Medicare & Medicaid Services (CMS), patients, advocates, providers, and researchers

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/25/2020
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; CAITLIN BOON;
Non FDA Participant/Group: Kyle Kinner, Sandra Eskin (The Pew Charitable Trusts);

Event Date: 02/28/2020
Location: Seattle, WA
Subject: 2020 Global Food Safety Initiative Conference
FDA Participant/Group: DONALD PRATER; JULIE MOSS; SHARON MAYL;
Non FDA Participant/Group: Members from industry, government, and academia

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

Event Date: 02/25/2020
Location: Silver Spring, MD
Subject: Blocking Act
FDA Participant/Group: KRISTIN DAVIS; MARYLL TOUFANIAN; RYAN CONRAD; LISA HELMANIS; DONALD BEERS;
Non FDA Participant/Group: Brian McCormick, Brian Savage, Christine Baeder, Michael Brzica, Scott Tomsky, Staci Julie (Teva Pharmaceuticals);

Event Date: 02/27/2020
Location: Silver Spring, MD
Subject: Blocking Act
FDA Participant/Group: GRAIL SIPES; KRISTIN DAVIS; RYAN CONRAD; LISA HELMANIS; MARYLL TOUFANIAN; DONALD BEERS;
Non FDA Participant/Group: Brian McCormick, Michael Brzica (Teva Pharmaceuticals); Dara Corrigan, Ryan Daniel (Fresenius Kabi); Chris Bowlin, Erik Komendant, Karin Hessler, Lisa Parks (Association for Accessible Medicines); Kevin Zive, Steve Giuli (Apotex Pharmaceuticals); Kurt Karst (Hyman, Phelps and McNamara);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 02/28/2020
Location: Silver Spring, MD
Subject: Systems Recognition; World Health Assembly
FDA Participant/Group: N/A
Non FDA Participant/Group: Matthew Hudson (EU Directorate General for Health and Food Safety);

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 02/27/2020
Location: Washington, DC
Subject: National Academies Workshop on Innovations in Pharmaceutical Manufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: David Lechuga-Ballesteros (AstraZeneca); Govind Rao (University of Maryland, Baltimore County); Akhilesh Bhambhani (Merck); Gintaras Reklaitis (Purdue University); Dan Blackwood (Pfizer);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/26/2020
Location: New York, NY
Subject: Silicon Valley Bank (SVB) Leerink 9th Annual Global Healthcare Conference Fireside Chat: Key CBER Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of industry

Event Date: 02/27/2020
Location: New York, NY
Subject: Immuno-Oncology 360: The Evolution of Regulatory Policy for Cell & Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Several stakeholders spanning the science and business communities

Event Date: 02/28/2020
Location: New Haven, CT
Subject: Yale School of Medicine/FDA Office of Minority Health - Health Equity Diversity Day: Shifting Toward Personalized Therapies to Address the Needs of Patients
FDA Participant/Group: DENISE HINTON; RICHARDAE ARAOJO;
Non FDA Participant/Group: Several representatives from Yale School of Medicine

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/24/2020
Location: Silver Spring, MD
Subject: Device Regulation Framework
FDA Participant/Group: ARIEL SEELEY; SONJA FULMER; ELIZABETH HILLEBRENNER; ELLEN FLANNERY; ANGELA KRUEGER;
Non FDA Participant/Group: Janet Trunzo, Zach Rothstein (AdvaMed); Phil Desjardins (Johnson & Johnson ); Diane Wurzburger (General Electric); Nicole Smith (Medtronic); Michael Pfleger (Alcon);

Event Date: 02/25/2020
Location: Silver Spring, MD
Subject: Medical Device Policy Issues
FDA Participant/Group: REENA PHILIP; BRENDAN O'LEARY; TIMOTHY STENZEL; COURTNEY LIAS; SON NGUYEN; ELLEN FLANNERY; ELIZABETH HILLEBRENNER; JACQUELINE CORRIGAN CURAY; TIMOTHY SOLBERG; BAKUL PATEL; MICHAEL PACANOWSKI; WENDY RUBINSTEIN;
Non FDA Participant/Group: Danelle Miller, Deepshikha Bhandari, Lesley Maloney, Neil Gunn, Richeal Cline (Roche);

Event Date: 02/26/2020
Location: Silver Spring, MD
Subject: Diabetic Devices, Cybersecurity and Renal Denervation Updates
FDA Participant/Group: BRAM ZUCKERMAN; COURTNEY LIAS; KELLIE KELM; MARK FELLMAN; JESSICA PAULSEN; WILLIAM MACFARLAND; DONALD ST PIERRE; BENJAMIN FISHER; VIVEK PINTO; BINITA ASHAR; OWEN FARIS; WILLIAM MAISEL; CAROLYN NEULAND; DOUGLAS SILVERSTEIN; MISTI MALONE; ANDREW FARB; DAVID SULLIVAN; JENNIFER STEVENSON; TIMOTHY STENZEL; ALAIN SILK;
Non FDA Participant/Group: Alejandro Galindo, Ali Dianaty, Bonnie Handke, Geoff Martha, John de Csepel, Leisa Martinez, Magnus Johansson, Noel Colon, Omar Ishrak, Richard Kuntz, Robert Vigersky, Sandeep Brar, Sean Salmon, Sidney Cohen, Tim Samsel, Vanessa DeBruin (Medtronic);

Event Date: 02/26/2020
Location: Silver Spring, MD
Subject: Verifying Accurate, Leading Edge IVCT Development (VALID) Act
FDA Participant/Group: TIMOTHY STENZEL; JOSEPH FRANKLIN; ELIZABETH HILLEBRENNER; ELLEN FLANNERY; WENDY RUBINSTEIN;
Non FDA Participant/Group: Nathan Brown (Akin Gump, LLP); Abram Barth, Alex Aravanis, Josh Ofman, Sharon Liang (GRAIL);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 02/28/2020
Location: Washington DC
Subject: National Academies of Sciences 80th Anniversary - New Challenges in Food & Nutrition to Inform Policy
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, government, and academia

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event